ELEVATED SUBSTANCE-P AND ACCELERATED CARTILAGE DEGRADATION IN RABBIT KNEES INJECTED WITH INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR

被引:89
作者
OBYRNE, EM
BLANCUZZI, V
WILSON, DE
WONG, M
JENG, AY
机构
[1] Research Department, Pharmaceuticals Division, Ciba-Geigy Corporation, Summit, New Jersey
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 07期
关键词
D O I
10.1002/art.1780330715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cytokines, interleukin‐1 (IL‐1), tumor necrosis factor α, and the neurotransmitter, substance P, have been implicated in the pathogenesis of arthritis because they stimulate synovial cells to secrete prostaglandin E2 and collagenase in vitro. We investigated in vivo changes in intraarticular substance P and the degradation of cartilage proteoglycan in response to intraarticular cytokine injections in rabbits. Twenty‐four hours after a single injection of 10 ng, 30 ng, or 100 ng of recombinant human IL‐1α (rHuIL‐1α) per joint, the mean ± SEM levels of substance P detected in the cell‐free joint lavage fluid were 250 ± 67 fmoles, 480 ± 60 fmoles, and 530 ± 130 fmoles (n = 4–5), respectively. The level of substance P in the contralateral knees injected with diluent was 58 ± 8 fmoles (n = 12). The level of substance P had increased by 2 hours after IL‐1 injection and remained elevated in the joint 48 hours after injection. Cytokineinduced proteoglycan depletion was also time‐ and dose‐dependent. Proteoglycan concentrations in articular cartilage dissected from the weight‐bearing condyles were calculated as the ratio of sulfated glycosaminoglycan measured using 1,9‐dimethylmethylene blue: hydroxyproline. After 48 hours, 10 ng, 30 ng, or 100 ng of rHuIL‐la per joint decreased proteoglycan levels by 9 ± 4%, 14 ± 4%, and 21 ± 3% (n = 8), respectively. Likewise, the injection of recombinant human tumor necrosis factor α induced depletion of intraarticular substance P and cartilage proteoglycan. Copyright © 1990 American College of Rheumatology
引用
收藏
页码:1023 / 1028
页数:6
相关论文
共 30 条
  • [11] A RADIOIMMUNOASSAY FOR MEASURING ALPHA-AMIDATING ENZYME-ACTIVITY
    JENG, AY
    WONG, M
    LOVATO, SJ
    ERION, MD
    GILLIGAN, JP
    [J]. ANALYTICAL BIOCHEMISTRY, 1990, 185 (02) : 213 - 219
  • [12] KIMBALL ES, 1988, J IMMUNOL, V141, P3559
  • [13] LE JM, 1987, LAB INVEST, V56, P234
  • [14] LEVINE JD, 1985, J RHEUMATOL, V12, P406
  • [15] SUBSTANCE-P ACTIVATION OF RHEUMATOID SYNOVIOCYTES - NEURAL PATHWAY IN PATHOGENESIS OF ARTHRITIS
    LOTZ, M
    CARSON, DA
    VAUGHAN, JH
    [J]. SCIENCE, 1987, 235 (4791) : 893 - 895
  • [16] EFFECT OF NEUROPEPTIDES ON PRODUCTION OF INFLAMMATORY CYTOKINES BY HUMAN-MONOCYTES
    LOTZ, M
    VAUGHAN, JH
    CARSON, DA
    [J]. SCIENCE, 1988, 241 (4870) : 1218 - 1221
  • [17] MARASCO WA, 1981, BIOCHEM BIOPH RES CO, V99, P1055
  • [18] MCGILLIS JP, 1987, FED PROC, V46, P196
  • [19] AN ANALYSIS OF THE AMERICAN-RHEUMATISM-ASSOCIATION CRITERIA FOR RHEUMATOID-ARTHRITIS
    MITCHELL, DM
    FRIES, JF
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (05): : 481 - 487
  • [20] PAYAN DG, 1984, J IMMUNOL, V132, P1601